PSIL
PSIL
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
About AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ATAI | Atai Beckley N.V | 11.52% | 576.81K | $2.31M |
 CMPS | COMPASS Pathways plc | 9.48% | 242.78K | $1.90M |
 SUPN | Supernus Pharmaceuticals, Inc. | 7.64% | 29.86K | $1.53M |
 MNMD | Mind Medicine (MindMed) Inc. | 7.57% | 108.13K | $1.52M |
 RLMD | Relmada Therapeutics, Inc. | 7.25% | 335.94K | $1.45M |
 GHRS | GH Research PLC | 6.32% | 70.57K | $1.27M |
 DRUG | Bright Minds Biosciences Inc. | 5.01% | 10.46K | $1.00M |
 NRXP | NRx Pharmaceuticals, Inc. | 4.95% | 404.87K | $991.92K |
 NBIX | Neurocrine Biosciences, Inc. | 4.91% | 7.00K | $984.06K |
 ALKS | Alkermes plc | 4.71% | 32.15K | $944.01K |
 ANRO | Alto Neuroscience, Inc. | 4.02% | 50.34K | $805.49K |
 ABBV | AbbVie Inc. | 3.61% | 3.10K | $722.90K |
 JNJ | Johnson & Johnson | 3.33% | 3.21K | $666.04K |
 NEUP | Neuphoria Therapeutics Inc. | 2.80% | 141.09K | $560.13K |
 STIM | Neuronetics, Inc. | 2.57% | 284.85K | $515.58K |
 QNTM | Quantum BioPharma Ltd. | 1.98% | 52.19K | $396.61K |
 KTTA | Pasithea Therapeutics Corp. | 1.55% | 320.40K | $310.78K |
 IXHL | Incannex Healthcare Limited | 1.36% | 697.85K | $271.46K |
 SILO | Silo Pharma, Inc. | 1.20% | 630.33K | $240.72K |
 VTGN | VistaGen Therapeutics, Inc. | 0.97% | 263.06K | $193.72K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
United Kingdom
Canada
AustraliaSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland United Kingdom Canada AustraliaHoldings (Top 20)
ATAI
Atai Beckley N.V
CMPS
COMPASS Pathways plc
SUPN
Supernus Pharmaceuticals, Inc.
MNMD
Mind Medicine (MindMed) Inc.
RLMD
Relmada Therapeutics, Inc.
GHRS
GH Research PLC
DRUG
Bright Minds Biosciences Inc.
NRXP
NRx Pharmaceuticals, Inc.
NBIX
Neurocrine Biosciences, Inc.
ALKS
Alkermes plc
ANRO
Alto Neuroscience, Inc.
ABBV
AbbVie Inc.
JNJ
Johnson & Johnson
NEUP
Neuphoria Therapeutics Inc.
STIM
Neuronetics, Inc.
QNTM
Quantum BioPharma Ltd.
KTTA
Pasithea Therapeutics Corp.
IXHL
Incannex Healthcare Limited
SILO
Silo Pharma, Inc.
VTGN
VistaGen Therapeutics, Inc.